Mednet Logo

What is your approach to REM behavior disorder not adequately treated with melatonin and clonazepam?

Community PollStarted

What is your treatment choice for REM behavior disorder not adequately treated with melatonin and clonazepam?

117 physicians have voted

Join Mednetto vote and see how they answered.

6 Answers
Mednet Member
Mednet Member
Neurology · St. Christopher's Hospital for Children
Answered on

Rule out comorbidities like sleep apnea or medications causing RBD. Optimize doses for melatonin and clonazepam, and consider dual therapy with these. Other options are gabapentin or pramipexole.

Thanks,
Sam Morkous

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Neurology · Columbia University Medical Center
Answered on

Make sure the melatonin is ER as RBD occurs in the early morning hours.

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Neurology · Northwestern University
Answered on

If both are at their max doses, then, in addition to making sure the bedroom environment is safe, I recommend rivastigmine.

HA

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Psychiatry · Thapar Renu K Office
Answered on

In my experience, patients who develop Parkinson’s disease can develop REM sleep behaviors.

In those cases, I have mostly counted on primary treatment of Parkinson’s disease.

With that, I have used clonazepam and melatonin.

Some young sleepwalking patients that I am aware of who were not in treatmen...

Join for free or sign in to see the full answer

Mednet Member
Mednet MemberInvited Expert
Psychiatry · Yale School of Medicine
Answered on

I would first ask if the diagnosis is correct, assuming this is diagnosed from a sleep study and sleep medicine. My answer would be really specific depending on the comorbidity. I wouldn't use DA in an older person, nor gabapentin in a patient with kidney issues.

Join for free or sign in to see the full answer

Mednet Member
Mednet Member
Psychiatry · M Health Fairview Masonic Childrens Hospital
Answered on

Ramelteon: From a pharmacological perspective, despite limited data and the absence of an extended‑release formulation, a trial of ramelteon is reasonable given its favorable safety profile, particularly in older adults. Worth trying in select patients.

Join for free or sign in to see the full answer